Cargando…
Severity, Course, and Predictors of Sleep Disruption Following Hematopoietic Cell Transplantation: A Secondary Data Analysis from the BMT CTN 0902 Trial
Sleep disruption has received little attention in hematopoietic cell transplantation (HCT). The goal of this study was to describe severity, course, and predictors of sleep disruption following HCT. A secondary data analysis was conducted of the Blood and Marrow Transplantation Clinical Trials Netwo...
Autores principales: | Jim, Heather S.L., Sutton, Steven, Majhail, Navneet, Wood, William A., Jacobsen, Paul B., Wingard, John R., Wu, Juan, Knight, Jennifer M., Syrjala, Karen L., Lee, Stephanie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064383/ https://www.ncbi.nlm.nih.gov/pubmed/29515249 http://dx.doi.org/10.1038/s41409-018-0138-0 |
Ejemplares similares
-
Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202
por: Lai, Tsung-Po, et al.
Publicado: (2022) -
Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors
por: Banerjee, Rahul, et al.
Publicado: (2020) -
Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial
por: Shindiapina, Polina, et al.
Publicado: (2021) -
Humoral Immunogenicity of Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study
por: Riches, Marcie L., et al.
Publicado: (2022) -
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
por: Chung, David J., et al.
Publicado: (2023)